1st Quarter - Report

CROSSROADS STRATEGIES, LLC for HALEON US HOLDINGS LLC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to coverage of over-the-counter products with FSAs and HSAs.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Policies impacting access to over-the-counter products; FY2026 Financial Services and General Government Appropriations Act process (H.R.5166/S.3290); H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5166 (119th), S. 3290 (119th), H.R. 7148 (119th)

Trade (domestic/foreign) TRD

Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.

Contacted: Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; Bureau of Industry and Security (BIS)

Medicare/Medicaid MMM

Education about the importance of OTC products and benefits under Medicare Advantage.

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.